SGLT2i / GLP-1 RA first-line alongside metformin per ADA 2026; individualise A1c, BP, lipid, and weight targets; titrate to target.
Authored pathway active · type-2-diabetes-in-adults.outpatient
SGLT2i / GLP-1 RA first-line alongside metformin per ADA 2026; individualise A1c, BP, lipid, and weight targets; titrate to target.
Guidelines: ADA Standards of Care in Diabetes 2026 · KDIGO 2022 Diabetes Management in CKD · ACC/AHA 2025 HTN Guideline (BP co-targets)
Phenotypes (4)
- Newly Diagnosed T2D HbA1c <86 mmol/mol
- T2D with Established Cardiovascular Disease or High CV Risk
- T2D with Diabetic Kidney Disease (DKD)
- T2D Requiring Insulin (HbA1c >86 on Oral Agents)
Pathway-scoped symptom and exam intake
Test this pathway's ROS and differential links
Uses LR engine endo.dm2.core.v1, then routes suggested engines into the workspace.
19-panel workspace
type-2-diabetes-in-adults · OutpatientStart patient workup
Open a scratch or linked encounter, add active problems, then keep labs, fluids, acid-base, and electrolyte tools beside the main workspace instead of losing context.
Encounter and problems
No encounter open. Add a problem to create a scratch encounter when none is open.
Multi-window tools
Unified
labs + fluids + acid-base
Labs
fast lab analyzer
Fluid
resuscitation and balance
Electrolytes
Na/K/Mg/Phos/Ca
ABG/VBG
compensation and mixed disorders
Popular entry points
6 quick-startsOr jump straight to the atlas
The Engine Atlas covers every authored disease package with setting chips and pathway badges. Open any engine to load its 19-panel workspace, backed by phenotype-aware reasoning and monitored by the Flow Assistant.